Clinical Trial Update: FP-101 for the Treatment of Hot Flashes in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for FP-101 in treating hot flashes in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hot Flashes

Drugs mentioned

• FP-101

Snippet

Sponsor: Fervent Pharmaceuticals | Conditions: Hot Flashes | Phase 2 | Status: COMPLETED